Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1GKE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,097
Award facts
- Contract value 100% obligated
- $11,097.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,097.21 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg, with an ultimate completion date of January 28, 2026. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, and specialized medical supplies. This contract award exemplifies the DLA's reliance on prime vendors to efficiently fulfill essential pharmaceutical procurement requirements for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1GKE?
SPE2DR26F1GKE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F1GKE worth?
The government has obligated $11,097 on SPE2DR26F1GKE.
Is contract SPE2DR26F1GKE an order under another contract?
Yes. SPE2DR26F1GKE is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GKE competed?
The extent of competition for SPE2DR26F1GKE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award